Company intelligence / Profile preview

Zymvol Biomodeling

Barcelona, Catalonia, Spainzymvol.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Zymvol Biomodeling has completed over 100 projects for global clients in the chemical and pharmaceutical industries. Their computational platform accelerates enzyme discovery/design by reducing lab work up to 90% and development time by up to 50%, with success rates above 75%. They have begun bringing custom-made enzyme kits to market.

Modalities: Enzyme (Biologic)Protein (Biologic)
Industry: Drug Discovery Services

Partnerships

AxploraMedichemSanofiGecco Biotech

Beyond the preview

Go deeper on Zymvol Biomodeling.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zymvol Biomodeling.

Explore the full profile